Home / Facilities / 2014676

The Belport Company, Inc DBA Gingi-Pak FDA Inspection Record

FEI 2014676 · Inspections, Form 483s, warning letters and import refusals

The Belport Company, Inc DBA Gingi-Pak is an FDA-registered facility (FEI 2014676) located in CAMARILLO, CA, US. RegDataLab tracks 4 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Nov 12, 2021: Voluntary Action Indicated (VAI)
Inspections on record
4 (2 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 12, 2021Voluntary Action Indicated (VAI)Written procedures not established/followed (21 CFR 211.67(b))
SOPs not followed / documented (21 CFR 211.100(b))
Procedures for non-sterile drug products (21 CFR 211.113(a))
Lack of written stability program (21 CFR 211.166(a))
and 3 more
Jan 23, 2019No Action Indicated (NAI)No citations listed
Sep 30, 2014No Action Indicated (NAI)Documentation (21 CFR 820.75(a))
Documentation (21 CFR 820.100(b))
Mar 14, 2012Voluntary Action Indicated (VAI)Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Lack of written stability program (21 CFR 211.166(a))
Review of representative number of batches (21 CFR 211.180(e)(1))
Documentation (21 CFR 820.75(a))
and 1 more

FDA record score

2 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 14, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

2 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAINov 12, 20216 x 0.251.5
Inspection classified VAIMar 14, 201210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 14, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 14, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 14, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 2, 2026Newest record Oct 22, 2026Current

Reviewing The Belport Company, Inc DBA Gingi-Pak as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check The Belport Company, Inc DBA Gingi-Pak yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
The Belport Company, Inc
Location
CAMARILLO, CA (US)
Source
device

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.